TWA
EDIT icon

TCI Wealth Advisors’s Editas Medicine EDIT Stock Holding History

TCI Wealth Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-330
Closed -$2.93K – 2547
2022
Q4 		$2.93K Hold
330
– – ﹤0.01% 1870
2022
Q3 		$4K Hold
330
– – ﹤0.01% 1589
2022
Q2 		$4K Buy
+330
New +$4.42K ﹤0.01% 1609
2022
Q1 		– Sell
-20
Closed -$1K – 2279
2021
Q4 		$1K Sell
20
-181
-90% -$6.23K ﹤0.01% 2182
2021
Q3 		$8K Sell
201
-2
-1% -$110 ﹤0.01% 1244
2021
Q2 		$11K Buy
203
+54
+36% +$2K ﹤0.01% 896
2021
Q1 		$6K Buy
149
+123
+473% +$7.01K ﹤0.01% 1134
2020
Q4 		$2K Hold
26
– – ﹤0.01% 1201
2020
Q3 		$1K Buy
26
+6
+30% +$195 ﹤0.01% 1305
2020
Q2 		$1K Hold
20
– – ﹤0.01% 1236
2020
Q1 		$0 Sell
20
-13
-39% -$328 ﹤0.01% 1538
2019
Q4 		$1K Buy
+33
New +$824 ﹤0.01% 1320

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

TCI Wealth Advisors's EDIT Position: Q1 2023 in Review

TCI Wealth Advisors sold out of Editas Medicine (EDIT) in Q1 2023, closing a stake of 330 shares — an estimated $2.93K sold.

TCI Wealth Advisors first reported a position in EDIT in Q4 2019 and held it in 12 quarters. The position peaked at $11K in Q2 2021. 234 funds tracked by Wall St. Rank hold EDIT as of Q1 2023.

  • TCI Wealth Advisors reported no remaining Editas Medicine position as of Q1 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 330 Editas Medicine shares in Q1 2023, an estimated $2.93K.
  • TCI Wealth Advisors first reported a position in Editas Medicine in Q4 2019 and held it in 12 quarters.
  • TCI Wealth Advisors's Editas Medicine position peaked at $11K in Q2 2021.
  • 234 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2023.

Based on TCI Wealth Advisors's 13F filing for Q1 2023, filed 3 May 2023.